| Literature DB >> 26633968 |
Mamadou Kaloga1, Ildevert Patrice Gbéry1, Vagamon Bamba2, Yao Isidore Kouassi1, Elidjé Joseph Ecra1, Almamy Diabate2, Sarah Kourouma1, Kouadio Celestin Ahogo1, Kouassi Alexandre Kouamé1, Komenan Kassi1, Kanga Kouame1, Abdoulaye Sangaré1.
Abstract
The specific objectives were to identify the epidemiology of cutaneous sarcoidosis and describe the clinical and laboratory aspects of the disease. Materials and Methods. We performed a descriptive cross-sectional study involving 24 referred cases of cutaneous sarcoidosis in 25 years (1990-2014) collected at Venereology Dermatology Department of the University Hospital of Treichville (Abidjan) both in consultation and in hospitalization. Results. The hospital frequency was one case per year. The average age was 42 years, ranging from 9 to 64. The sex ratio was 1. The shortest time interval between the appearance of the skin lesion and consultation of Dermatology Department at CHU Treichville was 3 months. The elementary lesions were represented primarily by a papule (18 cases), placard (3 cases), and nodule (2 cases) and mainly sat on the face and neck in 8 cases (38%). Extra cutaneous lesions were dominated by ganglion and respiratory involvement with 5 cases each followed by musculoskeletal damage in 3 cases. Chest radiography showed abnormality in 13 cases (54%). The pulmonary function test performed in 13 patients found 7 cases (54%) having restrictive ventilatory syndrome and 6 cases (46%) being normal. A tuberculin anergy was found in 11 cases (61%).Entities:
Year: 2015 PMID: 26633968 PMCID: PMC4655045 DOI: 10.1155/2015/802824
Source DB: PubMed Journal: Dermatol Res Pract ISSN: 1687-6113
Figure 1Nodule on the nose (Picture of Dr. Kouassi yao Isidore, CHU Treichville).
Figure 2Papule of the chest (Picture of Dr. Kouassi yao Isidore, CHU Treichville).
Radiographic images of sarcoidosis.
| Images | Number | Percentage (%) |
|---|---|---|
| Mediastinal lymphadenopathy isolated | 6 | 46 |
| Reaching isolated parenchymal | 5 | 39 |
| Mediastinal lymphadenopathy + parenchymal damage | 2 | 15 |
| Total | 13 | 100 |